青年成人癌症幸存者的社会健康、活动行为与生活质量
年轻成人癌症幸存者的社会健康、活动行为与生活质量:一项纵向研究
This longitudinal observational study examines how social health, including social support, social roles, loneliness, social anxiety, and social network characteristics, relates to physical activity, sedentary time, and quality of life among ethnically and racially diverse adolescent and young adult (AYA) cancer patients aged 18-39 years. The study follows participants over four clinically significant timepoints in the first 12 months after diagnosis (baseline near diagnosis, mid treatment, near end of treatment, and 12 month follow up). At each timepoint, patients complete questionnaires and wear a wrist worn accelerometer for one week.
研究概览
地位
条件
- 恶性实体肿瘤
- 霍奇金淋巴瘤
- 解剖学 I 期乳腺癌 AJCC v8
- 解剖学 IA 期乳腺癌 AJCC v8
- 解剖学 IB 期乳腺癌 AJCC v8
- 解剖学 II 期乳腺癌 AJCC v8
- 解剖学 IIA 期乳腺癌 AJCC v8
- 解剖学 IIB 期乳腺癌 AJCC v8
- 解剖学 III 期乳腺癌 AJCC v8
- 解剖学 IIIA 期乳腺癌 AJCC v8
- 解剖学 IIIB 期乳腺癌 AJCC v8
- 解剖学 IIIC 期乳腺癌 AJCC v8
- 预后 I 期乳腺癌 AJCC v8
- 预后 IA 期乳腺癌 AJCC v8
- 预后 IB 期乳腺癌 AJCC v8
- 预后 II 期乳腺癌 AJCC v8
- 预后 IIA 期乳腺癌 AJCC v8
- 预后 IIB 期乳腺癌 AJCC v8
- 预后 III 期乳腺癌 AJCC v8
- 预后 IIIA 期乳腺癌 AJCC v8
- 预后 IIIB 期乳腺癌 AJCC v8
- 预后性 IIIC 期乳腺癌 AJCC v8
- 非霍奇金淋巴瘤
- III 期子宫体癌 AJCC v8
- 临床 III 期皮肤黑色素瘤 AJCC v8
- 病理 IIIB 期皮肤黑色素瘤 AJCC v8
- 病理学阶段 IIIC 皮肤黑色素瘤 AJCC v8
- 病理IIID期皮肤黑色素瘤AJCC v8
- 临床 I 期皮肤黑色素瘤 AJCC v8
- 临床 IA 期皮肤黑色素瘤 AJCC v8
- 临床 IB 期皮肤黑色素瘤 AJCC v8
- 临床 II 期皮肤黑色素瘤 AJCC v8
- 临床 IIA 期皮肤黑色素瘤 AJCC v8
- 临床 IIB 期皮肤黑色素瘤 AJCC v8
- 临床 IIC 期皮肤黑色素瘤 AJCC v8
- 病理 I 期皮肤黑色素瘤 AJCC v8
- 病理 IA 期皮肤黑色素瘤 AJCC v8
- 病理学阶段 IB 皮肤黑色素瘤 AJCC v8
- 病理学 II 期皮肤黑色素瘤 AJCC v8
- 病理 IIA 期皮肤黑色素瘤 AJCC v8
- 病理 IIB 期皮肤黑色素瘤 AJCC v8
- 病理 IIC 期皮肤黑色素瘤 AJCC v8
- 病理学 III 期皮肤黑色素瘤 AJCC v8
- 病理 IIIA 期皮肤黑色素瘤 AJCC v8
- III 期结直肠癌 AJCC v8
- IIIA 期结直肠癌 AJCC v8
- IIIB 期结直肠癌 AJCC v8
- IIIC 期结直肠癌 AJCC v8
- I 期结直肠癌 AJCC v8
- II 期结直肠癌 AJCC v8
- IIA 期结直肠癌 AJCC v8
- IIB 期结直肠癌 AJCC v8
- IIC 期结直肠癌 AJCC v8
- I 期宫颈癌 AJCC v8
- IA 期宫颈癌 AJCC v8
- IA1 期宫颈癌 AJCC v8
- IA2 期宫颈癌 AJCC v8
- IB 期宫颈癌 AJCC v8
- IB1 期宫颈癌 AJCC v8
- IB2 期宫颈癌 AJCC v8
- II 期宫颈癌 AJCC v8
- IIA 期宫颈癌 AJCC v8
- IIA1 期宫颈癌 AJCC v8
- IIA2 期宫颈癌 AJCC v8
- IIB 期宫颈癌 AJCC v8
- III 期宫颈癌 AJCC v8
- IIIA 期宫颈癌 AJCC v8
- IIIB 期宫颈癌 AJCC v8
- IIIA 期子宫体癌 AJCC v8
- IIIB 期子宫体癌 AJCC v8
- IIIC 期子宫体癌 AJCC v8
- IIIC1 期子宫体癌 AJCC v8
- IIIC2 期子宫体癌 AJCC v8
- 恶性脑肿瘤
- III 期卵巢癌 AJCC v8
- IIIA 期卵巢癌 AJCC v8
- IIIA1 期卵巢癌 AJCC v8
- IIIA2 期卵巢癌 AJCC v8
- IIIB 期卵巢癌 AJCC v8
- IIIC 期卵巢癌 AJCC v8
- 中枢神经系统肿瘤
- III 期分化型甲状腺癌 AJCC v8
- III 期甲状腺髓样癌 AJCC v8
- I 期子宫体癌 AJCC v8
- IA 期子宫体癌 AJCC v8
- IB 期子宫体癌 AJCC v8
- II 期子宫体癌 AJCC v8
- 恶性睾丸肿瘤
- II 期卵巢癌 AJCC v8
- IIA 期卵巢癌 AJCC v8
- IIB 期卵巢癌 AJCC v8
- I 期卵巢癌 AJCC v8
- IA 期卵巢癌 AJCC v8
- IB 期卵巢癌 AJCC v8
- IC 期卵巢癌 AJCC v8
- 恶性骨肿瘤
- I 期分化型甲状腺癌 AJCC v8
- 第一阶段甲状腺髓样癌 AJCC v8
- II 期分化型甲状腺癌 AJCC v8
- II期甲状腺髓样癌AJCC v8
详细说明
PRIMARY OBJECTIVES:
I. Characterize trajectories of social health over the course of cancer treatment and into early survivorship; II. Investigate longitudinal and potentially reciprocal associations between social health and activity behaviors (physical activity and sedentary time) and their relationship to quality of life; III. Examine whether gender, race/ethnicity, socioeconomic status, and symptom burden moderate these associations.
OUTLINE:
Patients complete surveys over 40 minutes and wear an actigraph GT3X-BT accelerometer continuously for 7 days at baseline, 3, 6, and 12 months.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
California
-
Los Angeles、California、美国、90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles、California、美国、90033
- Los Angeles General Medical Center
-
-
Texas
-
Houston、Texas、美国、77030
- MD Anderson Cancer Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients diagnosed and/or treated with cancer between ages 18-39 at University of Southern California (USC) hospitals.
描述
Inclusion Criteria:
- Age 18-39 years at cancer diagnosis.
- Newly diagnosed (within past 3 months) with one of the following cancer types commonly seen in AYAs: testis, breast, thyroid, cervix, colorectal, brain/central nervous system, non Hodgkin lymphoma, uterine, melanoma, bones and joints, ovary, Hodgkin lymphoma, lung, or gastric cancer.
- Stage I-IV for solid tumors (AJCC 8th edition TNM staging) or I-IV for lymphomas (Ann Arbor staging).
- Receiving care at a participating USC affiliated hospital (USC Norris Comprehensive Cancer Center, Keck Hospital of USC, or Los Angeles General Medical Center) or MD Anderson Cancer Center.
- Clinician assessed expected survival greater than 12 months at time of diagnosis.
- Able to complete questionnaires and wear a wrist worn accelerometer.
- English or Spanish speaking.
Exclusion Criteria:
- Leukemia (excluded due to longer treatment duration and different care trajectory).
- Primary language other than English or Spanish.
- Cognitive or physical limitations that preclude completion of surveys or wearing an accelerometer.
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_ONLY
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Observational (actigraph, surveys)
Patients complete surveys and wear an actigraph GT3X-BT accelerometer continuously for 7 days at baseline, 3, 6, and 12 months. |
Wear an actigraph GT3X-BT accelerometer Complete survey
其他名称:
Complete survey |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in social role functioning
大体时间:Baseline up to 1 year
|
Assessed using the PROMIS Ability to Participate in Social Roles and Activities Short Form 4a, which measures limitations in participation in usual social roles and activities due to health (higher scores indicate better participation). |
Baseline up to 1 year
|
|
Change in perceived emotional support
大体时间:Baseline up to 1 year
|
Assessed using the PROMIS Emotional Support Short Form 4a, which measures perceived availability of people who provide emotional support, such as care, understanding, and someone to listen (higher scores indicate more emotional support). |
Baseline up to 1 year
|
|
Change in perceived informational support
大体时间:Baseline up to 1 year
|
Assessed using the PROMIS Informational Support Short Form 4a, which measures perceived availability of people who provide advice, information, and guidance (higher scores indicate more informational support). |
Baseline up to 1 year
|
|
Change in perceived instrumental support
大体时间:Baseline up to 1 year
|
Assessed using the PROMIS Instrumental Support Short Form 4a, which measures perceived availability of people who provide practical help and assistance with tasks (higher scores indicate more instrumental support). |
Baseline up to 1 year
|
|
Change in loneliness score
大体时间:Baseline up to 1 year
|
Assessed using the UCLA Loneliness Scale short form, which measures subjective feelings of loneliness and social disconnection (higher scores indicate greater loneliness). |
Baseline up to 1 year
|
|
Change in social anxiety symptoms
大体时间:Baseline up to 1 year
|
Assessed using the Mini Social Phobia Inventory (Mini SPIN), a brief validated measure of social anxiety and fear of social interactions (higher scores indicate greater social anxiety). |
Baseline up to 1 year
|
|
Change in social network density
大体时间:Baseline up to 1 year
|
Assessed using a study developed egocentric social network questionnaire in which participants list up to 10 important adult social contacts and indicate which contacts know each other; density is calculated as the proportion of possible ties that are present (higher values indicate a more densely connected network). |
Baseline up to 1 year
|
|
Change in proportion of supportive social ties
大体时间:Baseline up to 1 year
|
Assessed using a study developed egocentric social network questionnaire that measures whether each named social contact provides social support and encouragement for physical activity; the outcome is the proportion of social ties providing support (higher values indicate a more supportive network). |
Baseline up to 1 year
|
|
Change in frequency of social contact
大体时间:Baseline up to 1 year
|
Assessed using a study developed egocentric social network questionnaire that captures how often participants interact with each named social contact; the outcome is the average reported frequency of contact across alters (higher values indicate more frequent social contact). |
Baseline up to 1 year
|
|
Change in total daily physical activity
大体时间:Baseline up to 1 year
|
Assessed using a wrist worn ActiGraph GT3X BT accelerometer worn for 7 consecutive days at each time point. Raw data are converted to monitor independent movement summary (MIMS) units, and total daily physical activity is represented by average daily MIMS units across valid wear days (higher values indicate more physical activity). |
Baseline up to 1 year
|
|
Change in total daily sedentary time
大体时间:Baseline up to 1 year
|
Assessed using a wrist worn ActiGraph GT3X BT accelerometer worn for 7 consecutive days at each time point. Sedentary time is calculated from accelerometer data as average minutes per day spent in sedentary behavior (e.g., low movement periods while awake) across valid wear days (higher values indicate more sedentary time). |
Baseline up to 1 year
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Quality of Life
大体时间:Baseline up to 1 year
|
Patient reported quality of life using Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health 10, assessed at baseline and 12 month follow up. This is a 10-item patient-reported questionnaire measuring general physical, mental, and social health. Most questions use a 1-to-5 point scale. Higher numerical values consistently represent better health or lower symptoms. The survey produces two separate scores: Global Physical Health (GPH) and Global Mental Health (GMH). Raw response values are summed and converted into standardized T-scores where a score of 50 represents the U.S. general population average (standard deviation of 10). |
Baseline up to 1 year
|
|
Symptom Burden
大体时间:Baseline up to 1 year
|
Symptom burden assessed using the MD Anderson Symptom Inventory (MDASI) at all four timepoints. This survey is a multi-symptom patient-reported outcome (PRO) measure used to assess the severity of symptoms experienced by patients with cancer and the interference with daily living caused by these symptoms. |
Baseline up to 1 year
|
合作者和调查者
调查人员
- 首席研究员:Kimberly Miller, PhD、University of Southern California
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
- 泌尿生殖系统疾病
- 生殖器疾病
- 内分泌系统疾病
- 骨骼疾病
- 肌肉骨骼疾病
- 脑部疾病
- 中枢神经系统疾病
- 神经系统疾病
- 生殖器肿瘤,男性
- 泌尿生殖系统肿瘤
- 按部位分类的肿瘤
- 肿瘤
- 生殖器疾病,男性
- 男性泌尿生殖系统疾病
- 女性泌尿生殖系统疾病
- 女性泌尿生殖系统疾病和妊娠并发症
- 肠道疾病
- 免疫系统疾病
- 组织学类型的肿瘤
- 消化道肿瘤
- 消化系统肿瘤
- 消化系统疾病
- 肠胃疾病
- 肠道肿瘤
- 直肠疾病
- 子宫疾病
- 生殖器疾病,女性
- 内分泌腺肿瘤
- 肿瘤、腺体和上皮
- 腺癌
- 结肠疾病
- 卵巢疾病
- 附件疾病
- 生殖器肿瘤,女性
- 性腺疾病
- 淋巴系统疾病
- 淋巴增生性疾病
- 免疫增生性疾病
- 癌
- 宫颈疾病
- 神经外胚层肿瘤
- 肿瘤、生殖细胞和胚胎
- 肿瘤,神经组织
- 淋巴瘤
- 神经系统肿瘤
- 子宫肿瘤
- 神经内分泌肿瘤
- 肿瘤、导管、小叶和髓质
- 癌,神经内分泌
- 睾丸疾病
- 半身和淋巴疾病
- 结直肠肿瘤
- 卵巢肿瘤
- 宫颈肿瘤
- 淋巴瘤,非霍奇金
- 霍奇金病
- 脑肿瘤
- 中枢神经系统肿瘤
- 癌,髓质
- 睾丸肿瘤
- 骨肿瘤
其他研究编号
- 0S-20-10
- P30CA014089 (美国 NIH 拨款/合同)
- 0S-20-10 (其他标识符:USC / Norris Comprehensive Cancer Center)
- NCI-2021-05723 (注册表标识符:CTRP (Clinical Trial Reporting Program))
- R37CA256867 (美国 NIH 拨款/合同)
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.